In addition, specific laboratory investigations were statistically significant, as elevated levels of ALT, AST, and serum sphingolipids (particularly ceramide) with low levels of HDL cholesterol were all associated with NASH development and progression [73-77]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.